These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1164050)

  • 1. Activity of rifampicin on Mycobacterium ulcerans.
    Havel A; Pattyn SR
    Ann Soc Belg Med Trop; 1975; 55(2):105-8. PubMed ID: 1164050
    [No Abstract]   [Full Text] [Related]  

  • 2. Rifampicin in experimental Mycobacterium ulcerans infection.
    Stanford JL; Phillips I
    J Med Microbiol; 1972 Feb; 5(1):39-45. PubMed ID: 5022508
    [No Abstract]   [Full Text] [Related]  

  • 3. Susceptibility of Runyon Group I Mycobacteria to rifampicin.
    Saito H; Yamamoto S; Yamura T
    Hiroshima J Med Sci; 1972 Mar; 21(1):35-40. PubMed ID: 4661749
    [No Abstract]   [Full Text] [Related]  

  • 4. [Synergistic effects of davercin, rifampicin, ethambutol and isonicotinic acid hydrazide on selected standard strains of Mycobacterium in the in-vitro and in-vivo experiments].
    Janowiec M; Andrzejczyk Z; Szwedowicz I
    Pneumonol Pol; 1988 Jun; 56(6):278-82. PubMed ID: 3226945
    [No Abstract]   [Full Text] [Related]  

  • 5. Acquired resistance to rifampicin by Mycobacterium kansasii.
    Davidson PT; Waggoner R
    Tubercle; 1976 Dec; 57(4):271-3. PubMed ID: 1014109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A controlled trial of the treatment of Mycobacterium ulcerans infection with clofazimine.
    Revill WD; Morrow RH; Pike MC; Ateng J
    Lancet; 1973 Oct; 2(7834):873-7. PubMed ID: 4126917
    [No Abstract]   [Full Text] [Related]  

  • 7. Mycobacterium ulcerans infection: treatment with rifampin, hyperbaric oxygenation, and heat.
    Krieg RE; Wolcott JH; Meyers WM
    Aviat Space Environ Med; 1979 Sep; 50(9):888-92. PubMed ID: 496758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo studies of the action of rifampicin, clofazimine and B1912 on Mycobacterium marinum.
    Banerjee DK; Holmes IB
    Chemotherapy; 1976; 22(3-4):242-52. PubMed ID: 1269290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Contribution of heparin therapy in the medical treatment of Buruli ulcer apropos of 1 case].
    Kanga JM; Dion-Laine M; Kacou DE; Menan EI
    Bull Soc Pathol Exot; 2001 Mar; 94(1):32-5. PubMed ID: 11346980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiological abnormalities of the ileum associated with the use of clofazimine (Lamprene; B663) in the treatment of skin ulceration due to Mycobacterium ulcerans.
    de Bergeyck E; Janssens PG; de Muynck A
    Lepr Rev; 1980 Sep; 51(3):221-8. PubMed ID: 7442414
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of cutaneous infection due to Mycobacterium ulcerans.
    Song M; Vincke G; Vanachter H; Benekens J; Achten G
    Dermatologica; 1985; 171(3):197-9. PubMed ID: 2416603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of inhibitory effect of rifalazil and rifampicin against Mycobacterium ulcerans infection induced in mice].
    Nakanaga K; Saito H; Ishii N; Goto M
    Kekkaku; 2004 May; 79(5):333-9. PubMed ID: 15211873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Skin ulcer caused by Mycobacterium ulcerans in Cameroon. II. Bacteriological study].
    Boisvert H
    Bull Soc Pathol Exot Filiales; 1977; 70(2):125-31. PubMed ID: 579612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycobacterium ulcerans infection. Clinical and bacteriological study of the first cases recognized in South East Asia.
    Pettit JH; Marchette NJ; Rees RJ
    Br J Dermatol; 1966 Apr; 78(4):187-97. PubMed ID: 5910904
    [No Abstract]   [Full Text] [Related]  

  • 15. Mycobacterium fortuitum (TMC 1529): potentially immunogenic strain against experimental infections of Mycobacterium ulcerans in rats and mice.
    Singh NB; Srivastava A
    Indian J Exp Biol; 1985 Jul; 23(7):408-9. PubMed ID: 4077138
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cutaneous ulcer from Mycobacterium ulcerans. Apropos of 1 case in French Guiana].
    De Gentile PL; Mahaza C; Rolland F; Carbonnelle B; Verret JL; Chabasse D
    Bull Soc Pathol Exot; 1992; 85(3):212-4. PubMed ID: 1422270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimental aspects of the antimycobacterial activity of rifampicin].
    Blasi A; Di Perna A; Vinciguerra E
    Arch Tisiol Mal Appar Respir; 1967 Nov; 22(11):943-66. PubMed ID: 4978601
    [No Abstract]   [Full Text] [Related]  

  • 18. Mycobacterium fortuitum infections: a review with two illustrative cases.
    Halpern AA; Nagel DA
    Clin Orthop Relat Res; 1978 Oct; (136):247-52. PubMed ID: 729293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combination of gentamycin and amikacin with rifampicin, ethambutol and isoniazid on selected standard strains of Mycobacterium species in experiments done in vitro and in vivo].
    Janowiec M; Andrzejczyk Z; Marczewska J
    Pneumonol Pol; 1989 May; 57(5):300-7. PubMed ID: 2633149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chemotherapeutic regimens for nontuberculous mycobacterial infection based on in-vitro susceptibility test results].
    Tsukamura M; Yamori S
    Kekkaku; 1990 May; 65(5):349-57. PubMed ID: 2168003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.